Master the NEW fundamentals of drug pricing and rebates while gaining the strategic insight needed to navigate today’s rapidly changing pharmaceutical landscape.

Welcome to American Conference Institute’s (ACI’s) Passport to Proficiency on Rx Drug Pricing and Rebate REVISED Fundamentals. Designed for both emerging and experienced GP professionals, this comprehensive program delivers a practical understanding of pricing, reimbursement, and rebate methodologies across Medicaid, Medicare, 340B, VA/FSS, and other key government payor programs.

Through a combination of foundational instruction, advanced applications, and real-world case studies, attendees will explore the developments transforming the industry, including MFN pricing, next stage of IRA implementation, Medicare Drug Price Negotiation, PBM reform, state affordability initiatives, and the emerging TrumpRx framework and direct distribution models.

Build the knowledge, confidence, and strategic perspective needed to make informed decisions, manage risk, and succeed in an increasingly complex pricing and reimbursement environment.

Learn More

Key Program Modules

Week 1:
November 2 & 4

Drug Pricing and Rebate Essentials and Introduction to Medicaid

  • WAC & AWP
  • Interplay Between Programs
  • MDRP Fundamentals and Advanced Topics
  • State Transparency Laws

Week 2:
November 9 & 11

PHS 340B, VA and DOW Rx Pricing and Rebates

  • 340B Program Essentials
  • 340B Related Litigation
  • VA/FSS Contracting
  • Federal Ceiling Price

Week 3:
November 16 & 18

Medicare Pricing and Rebate Essentials and Advanced CMS Pricing and Rebate Topics

  • GLOBE, GUARD, and Medicaid’s GENEROUS
  • Inflation Rebates
  • Next Stage IRA Implementation
  • PBM Reform

Week 4:
November 30 & December 2

New Product Launches, Emerging Commercial Models and Strategic Financial Planning

  • TrumpRx & Direct Distribution
  • MFN Implications
  • Launch Pricing Strategies
  • Gross-to-Net Strategies

This intensive training program will help you:

UNDERSTAND how prices are established and how rebate systems work

DEFINE key pricing terms under Medicaid, Medicare, PHS 340B and other key government payor programs

MASTER complex pricing, rebate methodologies, and gross-to-net considerations

EXAMINE emerging developments in drug pricing, including MFN proposals, the next stage IRA implementation, PBM reform, and state affordability measures

EVALUATE pricing, reimbursement, and commercialization strategies for new products, emerging distribution models including Trump Rx, and future market challenges

Essential Education for Drug Pricing, Medicaid, Medicare, and Reimbursement Teams

Comprehensive Pricing & Rebate Training
Master essential pricing and rebate concepts across Medicaid, Medicare, 340B, VA, DOW programs through four weeks of immersive instruction.

Thought Leader-Led Instruction
Learn directly from thought leaders in Government Drug Pricing, including leading lawyers, in-house counsel, government pricing executives and consultants offering actionable guidance on today’s most critical drug pricing challenges.

Interactive Virtual Experience
Two interactive LAB (Learn, Apply, and Benchmark) sessions to provide hands-on learning and direct engagement with the instructors.

Flexible Online Format
Attend live or watch on demand—each session is designed for maximum flexibility and long-term access.

Continuing Legal and Professional Education
Earn CLE and CPE credits while building specialized knowledge in a rapidly evolving regulatory landscape.

Who Should Attend

LAW FIRMS
  • Attorneys with practice areas in:
    • Government Contracts and Managed Markets
    • Pharmaceuticals
    • Healthcare
    • Food & Drug
PHARMACIES
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Pricing
    • Business Development
GOVERNMENT AFFAIRS
  • Financial Analysts
PHARMACEUTICAL COMPANIES
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Pricing, Pricing Strategy, Pricing Analytics
    • Contracts and Reimbursement
    • Managed Markets
    • Managed Care
    • Government Programs
    • Medicaid/Medicare Rebates
    • Finance/Accounting/Audit
    • Government Affairs
  • Compliance Officers
PBMs
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Contract Management
    • Network Pharmacy
    • Retail Pharmacy Operations
    • Government Programs
    • Pricing and Operations
    • Clinical Operations
    • Industry Relations
PLANS
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Pharmacy Networks
    • Pharmaceutical Contracting
    • Clinical
    • Pharmacy Services

Trusted by Leading Organizations

Our course has been taken by professionals from top companies across various industries.
Join a growing community of learners from organizations such as:

  • Takeda Pharmaceuticals
  • Purdue Pharma LP
  • Daiichi Sankyo, Inc.
  • Harmony Biosciences Inc
  • Teva Pharmaceuticals
  • Novo Nordisk
  • Aimmune Therapeutics
  • Sanofi
  • Taiho Oncology Inc
  • Lexicon Pharmaceuticals Inc

Earn CPE Credits

American Conference Institute is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of Continuing Professional Education (CPE) on the National Registry of CPE Sponsors.

Boards of Accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: www.nasbaregistry.org

Learn more
“Excellent and very capable list of speakers. Not always this good and comprehensive at other programs.”
—VP, US Commercial Legal Lundbeck LLC
“All encompassing overview of government program and current issues.”
—Director of Pricing and Contracts, Horizon Pharmaceuticals

Questions?

Email us at [email protected]

Get in Touch

Ready to Register?

Secure your space now.

Register Now